[HTML][HTML] In vitro Evaluation of the Safety of Adalimumab for the Eye Under HTLV-1 Infection Status: A Preliminary Study
H Kurozumi-Karube, K Kamoi, N Ando… - Frontiers in …, 2020 - frontiersin.org
Adalimumab (ADA), a fully human monoclonal tumor necrosis factor (TNF)-α antibody, is
one of the most widely used biologics in the treatment of inflammatory diseases. However …
one of the most widely used biologics in the treatment of inflammatory diseases. However …
[引用][C] In vitro Evaluation of the Safety of Adalimumab for the Eye Under HTLV-1 Infection Status: A Preliminary Study
H Kurozumi-Karube, K Kamoi, N Ando… - … in Microbiology (Web …, 2020 - jglobal.jst.go.jp
Bathon JM Martin RW Fleischmann RM Tesser JR Schiff MH Keystone EC.(2000). A
comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N …
comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N …
In vitro Evaluation of the Safety of Adalimumab for the Eye Under HTLV-1 Infection Status: A Preliminary Study
H Kurozumi-Karube, K Kamoi, N Ando, M Uchida… - 2020 - agris.fao.org
Adalimumab (ADA), a fully human monoclonal tumor necrosis factor (TNF)-α antibody, is
one of the most widely used biologics in the treatment of inflammatory diseases. However …
one of the most widely used biologics in the treatment of inflammatory diseases. However …
In vitro Evaluation of the Safety of Adalimumab for the Eye Under HTLV-1 Infection Status: A Preliminary Study
H Kurozumi-Karube, K Kamoi, N Ando… - Frontiers in …, 2020 - pubmed.ncbi.nlm.nih.gov
Adalimumab (ADA), a fully human monoclonal tumor necrosis factor (TNF)-α antibody, is
one of the most widely used biologics in the treatment of inflammatory diseases. However …
one of the most widely used biologics in the treatment of inflammatory diseases. However …
In vitro Evaluation of the Safety of Adalimumab for the Eye Under HTLV-1 Infection Status: A Preliminary Study
H Kurozumi-Karube, K Kamoi, N Ando… - HTLV-1: Addressing …, 2021 - books.google.com
Tumor necrosis factor (TNF)-α antibody was introduced in the late 1990s as a molecularly
targeted agent and has since seen wide use against a variety of inflammatory diseases …
targeted agent and has since seen wide use against a variety of inflammatory diseases …
In vitro Evaluation of the Safety of Adalimumab for the Eye Under HTLV-1 Infection Status: A Preliminary Study.
H Kurozumi-Karube, K Kamoi, N Ando… - Frontiers in …, 2020 - europepmc.org
Adalimumab (ADA), a fully human monoclonal tumor necrosis factor (TNF)-α antibody, is
one of the most widely used biologics in the treatment of inflammatory diseases. However …
one of the most widely used biologics in the treatment of inflammatory diseases. However …
In vitro Evaluation of the Safety of Adalimumab for the Eye Under HTLV-1 Infection Status: A Preliminary Study
H Kurozumi-Karube, K Kamoi, N Ando… - Frontiers in …, 2020 - cir.nii.ac.jp
抄録< jats: p> Adalimumab (ADA), a fully human monoclonal tumor necrosis factor (TNF)-α
antibody, is one of the most widely used biologics in the treatment of inflammatory diseases …
antibody, is one of the most widely used biologics in the treatment of inflammatory diseases …
[HTML][HTML] In vitro Evaluation of the Safety of Adalimumab for the Eye Under HTLV-1 Infection Status: A Preliminary Study
H Kurozumi-Karube, K Kamoi, N Ando… - Frontiers in …, 2020 - ncbi.nlm.nih.gov
Adalimumab (ADA), a fully human monoclonal tumor necrosis factor (TNF)-α antibody, is
one of the most widely used biologics in the treatment of inflammatory diseases. However …
one of the most widely used biologics in the treatment of inflammatory diseases. However …